Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients - Qiu, X; Lu, D; Zhou, J; Wang, J; Yang, J; Meng, P; Hsueh, JL (Chin Med J, 1996)